...the initial target indications for Tempero, but Chris Cargill...
...targeting the mGlu family of receptors, said Cargill...
...what attracted us to it,” Jimenez told BioCentury.Cargill...

...president and CEO of Halozyme Therapeutics Inc. (NASDAQ:HALO); and Jill Zullo, VP of bioindustrials at Cargill...

...disease (see "CuraSen's SPARK" ). GPCR developer Sosei Group Corp. (Tokyo:4565) named interim CFO Chris Cargill...

...has resigned. SVP of Corporate Strategy and Head of Investor Relations and Corporate Communications Chris Cargill...

...through the sale of about 28 million shares at CHF0.60 to institutional investors and partner Cargill...

...million) Shares: 28 million Price: CHF0.60 Advisor: Piper Jaffray Investors: Institutional investors; Cargill Inc. Note: Cargill...

...through the sale of about 28 million shares at CHF0.60 to institutional investors and partner Cargill...

...Evolva and Cargill partnered to develop and commercialize fermentation-derived steviol glycosides. Steviol glycosides are extracted from...
...Cargill, a producer of food and agricultural products and services, will be responsible for commercialization. Cargill...
...will be eligible for mid-single to low double-digit royalties. Evolva Holding S.A. (SIX:EVE), Reinach, Switzerland Cargill...

...Emeryville, Calif. Business: Biomanufacturing Hired: Zanna McFerson as CBO, effective March 4, formerly VP at Cargill...

...division head of endocrinology, diabetes, bone and mineral disorders at Henry Ford Hospital . Victoria Cargill...
...disease outcome and adherence to therapy. The company's VAT data suggest that Egrifta is helpful." Cargill...